blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1870422

EP1870422 - Means for the treatment of diseases characterized by an excessive immune reaction [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.11.2008
Database last updated on 06.11.2024
Most recent event   Tooltip21.11.2008Application deemed to be withdrawnpublished on 24.12.2008  [2008/52]
Applicant(s)For all designated states
SuppreMol GmbH
Am Klopferspitz 19
82152 Martinsried / DE
[2007/52]
Inventor(s)01 / Jacob, Uwe
Guldeinstrasse 42
80339 Munich / DE
 [2007/52]
Representative(s)Bohmann, Armin K.
Bohmann
Anwaltssozietät
Nymphenburger Strasse 1
80335 München / DE
[N/P]
Former [2007/52]Bohmann, Armin K.
Bohmann & Loosen Anwaltssozietät Nymphenburger Strasse 1
80335 München / DE
Application number, filing date06012684.420.06.2006
[2007/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1870422
Date:26.12.2007
Language:EN
[2007/52]
Search report(s)(Supplementary) European search report - dispatched on:EP24.10.2006
ClassificationIPC:C07K16/28, A61P37/00, C12N15/13, A61K39/00
[2007/52]
CPC:
C07K16/283 (EP); A61P37/00 (EP); A61K2039/505 (EP)
Designated contracting states(deleted) [2008/36]
Former [2007/52]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Mittel zur Behandlung von Erkrankungen, die durch eine übermässige Immunreaktion gekennzeichnet sind[2007/52]
English:Means for the treatment of diseases characterized by an excessive immune reaction[2007/52]
French:Moyens pour le traitement de maladies caractérisées par une réaction immunitaire excessive[2007/52]
Examination procedure27.06.2008Application deemed to be withdrawn, date of legal effect  [2008/52]
06.08.2008Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2008/52]
Fees paidPenalty fee
Additional fee for renewal fee
30.06.200803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]WO2004016750  (MACROGENICS INC [US], et al) [AD] 1-28 * page 12, line 12 - line 34 * * page 13, line 28 - line 33 *;
 [XD]WO2005051999  (MAX PLANCK GESELLSCHAFT [DE], et al) [XD] 1-28 * page 8, line 11 - line 25; figure 1 * * page 9, line 5 - line 8 * * page 13, line 6 - line 21 * * page 20, line 30 - line 34 *;
 [A]WO2006028956  (GENENTECH INC [US], et al) [A] * the whole document *;
 [A]  - NAKAMURA AKIRA ET AL, "Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.", EXPERT OPINION ON THERAPEUTIC TARGETS. FEB 2005, (200502), vol. 9, no. 1, ISSN 1744-7631, pages 169 - 190, XP009073504 [A] * the whole document *

DOI:   http://dx.doi.org/10.1517/14728222.9.1.169
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.